Leiv Lea

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Leiv Lea
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leiv Lea:

Company Role Class Num Shares Value Price $ Report Date Ownership
Corvus Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 400,000 04 Dec 2025 Direct

Insider Reports Filed by Leiv Lea

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRVS Corvus Pharmaceuticals, Inc. 04 Dec 2025 1 $0 4 Chief Financial Officer 08 Dec 2025, 16:21
CRVS Corvus Pharmaceuticals, Inc. 20 Dec 2024 1 $0 4 Chief Financial Officer 23 Dec 2024, 16:39
CRVS Corvus Pharmaceuticals, Inc. 06 Dec 2023 1 $0 4 Chief Financial Officer 08 Dec 2023, 16:08
CRVS Corvus Pharmaceuticals, Inc. 13 Dec 2022 2 +$25,639 4 Chief Financial Officer 15 Dec 2022, 15:33
CRVS Corvus Pharmaceuticals, Inc. 11 Aug 2022 1 $0 4 Chief Financial Officer 15 Aug 2022, 18:49
CRVS Corvus Pharmaceuticals, Inc. 16 Mar 2022 2 +$77,045 4 Chief Financial Officer 17 Mar 2022, 19:10
CRVS Corvus Pharmaceuticals, Inc. 09 Sep 2021 1 $0 4 Chief Financial Officer 13 Sep 2021, 16:59